Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle


Obesity, defined as a body mass index (BMI) ≥30 is an independent risk factor in breast cancer and is correlated with shorter survival and enhanced recurrence rates. The present subgroup analysis of the German BRENDA-cohort aimed to investigate the correlation between BMI, recurrence-free survival (RFS) and adjuvant endocrine therapy. In this subgroup… (More)
DOI: 10.1007/s10549-011-1874-7


4 Figures and Tables

Slides referencing similar topics